Mexico topped the charges for global emerging markets inflows last month according to Bank of America-Merrlll Lynch. We have Mexico exposure including a share which hit a new 52-week high after an extremely bold move last week. We tell our paid subscribers about that below. We also report on the conversion plans by one of our yield stocks, and how this will play out, and about another tax inversion play discovered by Morningstar Friday, which I reported on weeks ago. Then, more restructuring at yet another drug firm is coming. In addition there is news from Britain, China, Singapore, Canada, Ireland, Belgium, Israel, and Mexico.

*Today's Financial Times featured a lead article and full-page apology from Sir Andrew Witty of GlaxoSmithKline and the Brits reacted positively to his talk of spinning off the over the counter and consumer drug side of GSK to shareholders. The price rose 2.9% in London trading this morning, making up for some of last week's loss after a disappointing Q2. We own this baby in our yield portfolio.

*Similarly, after a 7% drop in its Q2 sales to GBP 2.3 bn y/o/y, Reckitt Benckiser also promised goodies to its shareholders, notably that it will spin off to them its drug sub, rather than trying to find a buyer. The major product of the sub is Suboxone, a sublingual opiate substitute used to stabilize heroin addicts, which is off-patent and vulnerable to generics. The edge it has is that addicts' kids do not poison themselves by taking parental under-tongue meds. The new RBGLY entity will be London-listed. More details to come.

*Morningstar's tax inversion pick, like mine, is Alkermes, ALKS, of Ireland, home of the 12.5% corporate earnings tax. WTYF, we told you first. I like ALKS in its own write as well, thanks to its research into multiple sclerosis and other neuro disease drugs. It may become a target for Teva.

*The Mexican market reacted with wild enthusiasm to the plan by Fibra Uno to place its pesos on a gamble on a huge site to be acquired from the El Mann family which controls FBASF, subject to approvals by independent directors in a committee. The stock hit a new 12-mo high up over 2.5%, in the news, at NMP 46 plus.

*Our other Mexico plays are Mexican Equity and Income Fund, MXE and Mexichem, a maker of plastic pipes which is heavily involved in the future independence of Pemex privatization of its chemical producer business.

*Global Logistics Properties of Singapore signed an accord with the jv of BMW and Brilliance China Automotive to lease to them over 200,000 sq ft of facilities near Guangzhou (Canton). This plugs into the huge potential of China's auto market which is growing 8% a year for the next 5 years at least, according to McKinsey research. Once you have taken delivery of your car, you need after sales and spare parts. So that market will grow even faster. GBTZF is moving to becoming an issuer of real estate funds to sovereign wealth funds, starting with Singapore, but also including China, Japan, and Canada pension funds.

*Tencent will work via its TJD partner to bring China the Microsoft X-box One to enable more gaming. Chinese can use Weixin or Mobile QQ to pre-order the video game app from MSFT for the equivalent of $81 starting this week, for delivery in Sept. This is a new alignment helping TCTZF and its parent Naspers fight Alibaba. NPSNY.

*Mellanox was bought back by Patti the Biotech maven; I didn't join her mainly for fear of the Israeli firm losing its edge from the Infiniband links it makes in the new world of 4G cellphones. But Patti was right. MLNX also has just signed up with a new major, in this case IBM, for whom it will provide cloud infrastructure. I worry about MLNX's edge because it seems too linked to Intel which may wind up creating its own connectors.

*Galapagos announced a new issue of 666.7 thousand warrants at euros 14.54, the 2nd this year. Each one adds about 8% to the potential shares outstanding but will not trade until exercised by its officers and staff.

*Cameco was downrated to hold from buy by brokerage Cantor Fitzgerald. Nuclear piower is the only low-carbon energy source which makes economic sense, according to this week's Economist. I am a confirmed nuclear nut.

*As part of our new policy of sharing my idea which were not included in the model portfolio, one of my best holdings in Japan was not recommended by our local guru, Chris Loew. It is up 7.2% in the last week. I bought Fanuc because I visited their robot factory in France ages ago. It gained because of the low yen.

*Another of my picks performed even better. Nokia rose 8.7% in euros last week. This one is in the model portfolio.